---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-089008"
form_type: "8-K"
ticker: "OGN"
cik: "0001821825"
company_name: "Organon & Co."
filed_at: "2026-07-31T12:23:43+00:00"
generated_at: "2026-07-31T12:25:05.555979+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# Organon furnishes supplemental non-GAAP Q2 2026 metrics; merger with Sun Pharma pending

## Summary
- Company released Q2 2026 financial results via Form 10-Q, not a press release, due to pending merger with Sun Pharmaceutical Industries.
- Supplemental non-GAAP metrics for Q2 2026 are furnished in Exhibit 99.1 but no specific figures are provided in the filing text.
- Customary earnings press release and conference call suspended for the quarter.
- Non-GAAP measures are intended to supplement GAAP results; full GAAP disclosures are in the 10-Q filed July 31, 2026.

## SEC filing metadata
- accession: 0001104659-26-089008
- form_type: 8-K
- ticker: OGN
- cik: 0001821825
- company_name: Organon & Co.
- filed_at: 2026-07-31T12:23:43+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821825/000110465926089008/0001104659-26-089008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821825/000110465926089008/tm2621744d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-089008
- JSON: https://secwatch.observer/filing/0001104659-26-089008.json
- Plain text: https://secwatch.observer/filing/0001104659-26-089008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.